Individual capacity for repair of DNA damage and potential uses of stem cell lines for clinical applications: a matter of (genomic) integrity

References

• Yalçin B, Kremer LC, van Dalen EC. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma. Cochrane Database Syst Rev. 2015;(10):CD006301. DOI: 10.1002/14651858.CD006301.pub3
   PubMed Web of Science ®Google Scholar
• Chivu-Economescu M, Rubach M. Hematopoietic Stem Cells Therapies. Curr Stem Cell Res Ther. 2017;12(2):124–133.
   PubMed Web of Science ®Google Scholar
• Muraro PA, Martin R, Mancardi GL, et al. Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis. Nat Rev Neurol. 2017;13(7):391–405.
   PubMed Web of Science ®Google Scholar
• Penati R, Fumagalli F, Calbi V, et al. Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I. J Inherit Metab Dis. 2017;40(4):543–554.
   PubMed Web of Science ®Google Scholar
• Zeher M, Papp G, Nakken B, et al. Hematopoietic stem cell transplantation in autoimmune disorders: From immune-regulatory processes to clinical implications. Autoimmun Rev. 2017;16(8):817–825.
   PubMed Web of Science ®Google Scholar
• Holyoake TL, Alcorn MJ, Richmond L, et al. CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens. Bone Marrow Transplant. 1997;19(11):1095–1101.
   PubMed Web of Science ®Google Scholar
• Draper JS, Smith K, Gokhale P, et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol. 2004;22:53–54.
   PubMed Web of Science ®Google Scholar
• Hovatta O, Jaconi M, Töhönen V, et al. A teratocarcinoma-like human embryonic stem cell (hESC) line and four hESC lines reveal potentially oncogenic genomic changes. PLoS One. 2010;5(4):e10263. DOI:10.1371/journal.pone.0010263
   PubMed Web of Science ®Google Scholar
• Vaxman I, Ram R, Gafter-Gvili A, et al. Secondary malignancies following high dose therapy and autologous hematopoietic cell transplantation-systematic review and meta-analysis. Bone Marrow Transplant. 2015;50(5):706–714.
   PubMed Web of Science ®Google Scholar
• Becker KA, Ghule PN, Therrien JA, et al. Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. J Cell Physiol. 2006;209(3):883–893.
   PubMed Web of Science ®Google Scholar
• Bárta T, Vinarský V, Holubcová Z, et al. Human embryonic stem cells are capable of executing G1/S checkpoint activation. Stem Cells. 2010;28(7):1143–1145.
   PubMed Web of Science ®Google Scholar
• Arabadjiev A, Petkova R, Momchilova A, et al. Of mice and men – differential mechanisms of maintaining the undifferentiated state in mESC and hESC. BioDiscovery. 2012;3:e8927. DOI:10.7750/BioDiscovery.2012.3.1
   Google Scholar
• Laugesen A, Helin K. Chromatin repressive complexes in stem cells, development, and cancer. Cell Stem Cell. 2014; 14(6):735–751.
   PubMed Web of Science ®Google Scholar
• Nagaria P, Robert C, Rassool FV. DNA double-strand break response in stem cells: mechanisms to maintain genomic integrity. Biochim Biophys Acta. 2013;1830(2):2345–2353.
   PubMed Web of Science ®Google Scholar
• Zhao B, Zhang WD, Duan YL, et al. Filia is an ESC-specific regulator of DNA damage response and safeguards genomic stability. Cell Stem Cell. 2015;16(6):684–698.
   PubMed Web of Science ®Google Scholar
• Pero RW, Bryngelsson C, Mitelman F, et al. Interindividual variation in the responses of cultured human lymphocytes to exposure from DNA damaging chemical agents: interindividual variation to carcinogen exposure. Mutat Res. 1978;53(3):327–341.
   PubMed Web of Science ®Google Scholar
• Chakarov S, Petkova R, Russev GCh. Individual capacity for detoxification of genotoxic compounds and repair of DNA damage. Commonly used methods for assessment of capacity for DNA repair. BioDiscovery. 2014;11:e8958. DOI:10.7750/BioDiscovery.2014.11.2
   Google Scholar
• Vodicka P, Kumar R, Stetina R, et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis. 2004;25(5):757–763.
   PubMed Web of Science ®Google Scholar
• Shkarupa VM, Mishcheniuk OY. Polymorphism of DNA repair gene XPD Lys751Gln and chromosome aberrations in lymphocytes of thyroid cancer patients exposed to ionizing radiation due to the Chornobyl accident. Exp Oncol. 2016;38(4):257–260.
   PubMedGoogle Scholar
• Jacobsohn DA, Vogelsang GB. Acute graft versus host disease. Orphanet J Rare Dis. 2007;2:35. DOI: 10.1186/1750-1172-2
   PubMed Web of Science ®Google Scholar
• Valcárcel D, Martino R, Caballero D, et al. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival. J Clin Oncol. 2008;26(4):577–584.
   PubMed Web of Science ®Google Scholar
• Arora M, Lindgren B, Basu S, et al. Polymorphisms in the base excision repair pathway and graft-versus-host disease. Leukemia. 2010;24:1470–1475.
   PubMed Web of Science ®Google Scholar
• Kornblit B, Masmas T, Petersen SL, et al. Association of HMGB1 polymorphisms with outcome after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2010;16:239–252.
   PubMed Web of Science ®Google Scholar
• Thyagarajan B, Lindgren B, Basu S, et al. Association between genetic variants in the base excision repair pathway and outcomes after hematopoietic cell transplantations. Biol Blood Marrow Transplant. 2010;16:1084–1089.
   PubMed Web of Science ®Google Scholar
• Diamond HR, Ornellas MH, Orfao A, et al. Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms. J Hematol Oncol. 2011;4:39. DOI:10.1186/1756-8722-4-39
   PubMed Web of Science ®Google Scholar
• Nijnik A, Woodbine L, Marchetti C, et al. ANA DNA repair is limiting for haematopoietic stem cells during ageing. Nature. 2007;447(7145):686–690.
   PubMed Web of Science ®Google Scholar
• Niedernhofer LJ. DNA repair is crucial for maintaining hematopoietic stem cell function. DNA Repair (Amst). 2008;7(3):523–529.
   PubMed Web of Science ®Google Scholar
• Desai A, Qing Y, Gerson SL. Exonuclease 1 is a critical mediator of survival during DNA double strand break repair in nonquiescent hematopoietic stem and progenitor cells. Stem Cells. 2014;32(2):582–593.
   PubMed Web of Science ®Google Scholar
• Abdallah BM, Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther. 2008;15(2):109–116.
   PubMed Web of Science ®Google Scholar
• Perin L, Sedrakyan S, Da Sacco S, et al. Characterization of human amniotic fluid stem cells and their pluripotential capability. Methods Cell Biol. 2008;86:85–99.
   PubMed Web of Science ®Google Scholar
• Nicolay NH, Rühle A, Perez RL, et al. Mesenchymal stem cells exhibit resistance to topoisomerase inhibition. Cancer Lett. 2016;374(1):75–84.
   PubMed Web of Science ®Google Scholar
• Hare I, Gencheva M, Evans R, et al. In vitro expansion of bone marrow derived mesenchymal stem cells alters DNA double strand break repair of etoposide induced DNA damage. Stem Cells Int. 2016;2016:8270464. DOI:10.1155/2016/8270464
   PubMed Web of Science ®Google Scholar
• Pal R, Venkataramana NK, Bansal A, et al. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study. Cytotherapy. 2009;11(7):897–911.
   PubMed Web of Science ®Google Scholar
• Lee JS, Hong JM, Moon GJ, et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells. 2010;28(6):1099–1106.
   PubMed Web of Science ®Google Scholar
• Kobold S, Guhr A, Kurtz A, et al. Human embryonic and induced pluripotent stem cell research trends: complementation and diversification of the field. Stem Cell Rep. 2015;4(5):914–925.
   PubMed Web of Science ®Google Scholar
• Chin MH, Mason MJ, Xie W, et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell. 2009;5(1):111–123.
   PubMed Web of Science ®Google Scholar
• Feng Q, Lu SJ, Klimanskaya I, et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells. 2010;28(4):704–712.
   PubMed Web of Science ®Google Scholar
• Ghosh Z, Wilson KD, Wu Y, Hu S, et al. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One. 2010;5(2):e8975. DOI:10.1371/journal.pone.0008975
   PubMed Web of Science ®Google Scholar
• Doi D, Samata B, Katsukawa M, et al. Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Rep. 2014;2(3):337–350.
   PubMed Web of Science ®Google Scholar
• Schwartz SD, Regillo CD, Lam BL, et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet. 2015;385(9967):509–516.
   PubMed Web of Science ®Google Scholar
• Menasché P, Vanneaux V, Fabreguettes JR, et al. Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience. Eur Heart J. 2015;36(12):743–750.
   PubMed Web of Science ®Google Scholar
• Yabe SG, Fukuda S, Takeda F, et al. Efficient generation of functional pancreatic β-cells from human induced pluripotent stem cells. J Diabetes. 2017;9(2):168–179.
   PubMed Web of Science ®Google Scholar
• Tilgner K, Neganova I, Moreno-Gimeno I, et al. A human iPSC model of Ligase IV deficiency reveals an important role for NHEJ-mediated-DSB repair in the survival and genomic stability of induced pluripotent stem cells and emerging haematopoietic progenitors. Cell Death Differ. 2013;20(8):1089–1100.
   PubMed Web of Science ®Google Scholar
• Masotti A, Celluzzi A, Petrini S, et al. Aged iPSCs display an uncommon mitochondrial appearance and fail to undergo in vitro neurogenesis. Aging (Albany NY). 2014;6(12):1094–1108.
   PubMedGoogle Scholar
• Simara P, Tesarova L, Rehakova D, et al. DNA double-strand breaks in human induced pluripotent stem cell reprogramming and long-term in vitro culturing. Stem Cell Res Ther. 2017;8:73. DOI:10.1186/s13287-017-0522-5
   PubMed Web of Science ®Google Scholar
• Nagaria PK, Robert C, Park TS, et al. High-fidelity reprogrammed human IPSCs have a high efficacy of DNA repair and resemble hESCs in their MYC transcriptional signature. Stem Cells Int. 2016;2016:3826249. DOI:10.1155/2016/3826249
   PubMed Web of Science ®Google Scholar
• Garber K. RIKEN suspends first clinical trial involving induced pluripotent stem cells. Nat Biotechnol. 2015;33(9):890–891.
   PubMed Web of Science ®Google Scholar
• Takashima K, Inoue Y, Tashiro S, et al. Lessons for reviewing clinical trials using induced pluripotent stem cells: examining the case of a first-in-human trial for age-related macular degeneration. Regen Med. 2018;13(2):123–128.
   PubMed Web of Science ®Google Scholar
• Gazdic M, Volarevic V, Harrell CR, et al. Stem cells therapy for spinal cord injury. Int J Mol Sci. 2018;19(4):1039. DOI: 10.3390/ijms19041039
   Web of Science ®Google Scholar
• Takahashi J. Stem cells and regenerative medicine for neural repair. Curr Opin Biotechnol. 2018;52:102–108.
   PubMed Web of Science ®Google Scholar
• Serrano L, Liang L, Chang Y, et al. Homologous recombination conserves DNA sequence integrity throughout the cell cycle in embryonic stem cells. Stem Cells Dev. 2011;20(2):363–374.
   PubMed Web of Science ®Google Scholar
• Cattoglio C, Zhang ET, Grubisic I, et al. Functional and mechanistic studies of XPC DNA-repair complex as transcriptional coactivator in embryonic stem cells. Proc Natl Acad Sci USA. 2015;112(18):E2317–2326.
   PubMed Web of Science ®Google Scholar
• Ho JJ, Cattoglio C, McSwiggen DT, et al. Regulation of DNA demethylation by the XPC DNA repair complex in somatic and pluripotent stem cells. Genes Dev. 2017;31(8):830–844.
   PubMed Web of Science ®Google Scholar
• Al-Khalaf MH, Blake LE, Larsen BD, et al. Temporal activation of XRCC1-mediated DNA repair is essential for muscle differentiation. Cell Discov. 2016;2:15041. DOI:10.1038/celldisc.2015.41
   PubMed Web of Science ®Google Scholar
• Cyranoski D. Trials of embryonic stem cells to launch in China. Nature. 2017;546(7656):15–16.
   PubMed Web of Science ®Google Scholar
• Hanson C, Caisander G. Human embryonic stem cells and chromosome stability. APMIS. 2005;113(11-12):751–755.
   PubMed Web of Science ®Google Scholar
• Reynolds L. The success of stem cell transplantations and the potential post-transplantation complications may be dependent, among other factors, on the capacity of the recipient and the transplanted cells to repair DNA damage. BioDiscovery. 2016;19:e9076. DOI:10.3897/BioDiscovery.19.e9076
   Google Scholar